Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-30

Clinical Trial Update: Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 1/2 clinical trial evaluating artesunate for Friedreich Ataxia. The study was conducted by the Institut National …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Friedreich Ataxia | Phase 1, Phase 2 | Status: COMPLETED